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ApoptosisSubmillimolar concentrations of cytotoxic bile acids (BAs) induce cell death via apoptosis. On the other hand,
several cytoprotective BAs were shown to prevent apoptosis in the same concentration range. Still, the mech-
anisms by which BAs trigger these opposite signaling effects remain unclear. This study was aimed to deter-
mine if cytotoxic and cytoprotective BAs, at physiologically active concentrations, are able to modulate the
biophysical properties of lipid membranes, potentially translating into changes in the apoptotic threshold of
cells. Binding of BAs to membranes was assessed through the variation of ﬂuorescence parameters of suitable
derivatized BAs. These derivatives partitioned with higher afﬁnity to liquid disordered than to the cholesterol-
enriched liquid ordered domains. Unlabeled BAswere also shown to have a superﬁcial location upon interaction
with the lipid membrane. Additionally, the interaction of cytotoxic BAs with membranes resulted in membrane
expansion, as concluded from FRET data. Moreover, it was shown that cytotoxic BAs were able to signiﬁcantly
disrupt the ordering of the membrane by cholesterol at physiologically active concentrations of the BA, an effect
not associatedwith cholesterol removal. On the other hand, cytoprotective bile acids had no effect onmembrane
properties. It was concluded that, given the observed effects on membrane rigidity, the apoptotic activity of
cytotoxic BAs could be potentially associated with changes in plasma membrane organization (e.g. modulation
of lipid domains) or with an increase in mitochondrial membrane afﬁnity for apoptotic proteins.
© 2013 Elsevier B.V. All rights reserved.1. Introduction
Bile acids (BAs) are naturally-occurring detergents that solubilize die-
tary lipids in the intestinal tract and in the bile [1]. Submillimolar concen-
trations of hydrophobic BAs, such as deoxycholic acid (DCA) or,N-di-methyl-N-hydroxyethyl)
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l rights reserved.chenodeoxycholic (CDCA), activate cell death receptors in a ligand inde-
pendent manner [2], stimulate p53, EF2-1 and Cyclin D1 expression [3],
induce oxidative damage [4], promote both Bcl-2 associated protein X
(Bax) translocation to mitochondria [5] and mitochondrial dysfunction
[4,6]. Any of thesemodiﬁcations alone are sufﬁcient for caspase activation
and initiation of apoptosis [3,7]. On the other hand,more hydrophilic BAs,
such as ursodeoxycholic acid (UDCA) and tauroursodeoxycholic acid
(TUDCA), prevent the formation of reactive oxygen species [6], Bax trans-
location to mitochondrial membrane [8], mitochondrial dysfunction [4]
and death-receptor induced apoptosis [9], ultimately inhibiting apoptosis.
These hydrophilic or cytoprotective BAs are also known to activate
pro-survival proteins such as the phosphatidyl inositol 3-phosphate
(PI3K), the serine threonine kinase Akt and themitogen-activated protein
(MAP) Kinase Kinase Kinase [10]. Moreover, both pro-apoptotic proteins
Cyclin D1 and EF2-1 have their expression levels decreased by UDCA or
TUDCA incubation [11,12], even in the presence of cytotoxic DCA [3].
The molecular mechanisms associated with such different outcomes,
and produced by these very similar molecules, remain elusive.
Since BAs are amphipathic molecules, biological membranes might
constitute one of the targets for their biological actions. At the range of
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niﬁcant enrichment of BAs in cellular membranes is expected to occur.
However, little is known regarding the effects of BA interaction with
lipid membranes at submillimolar concentrations. The aim of this study
was the detailed characterization of these effects onmembraneswith dif-
ferent lipid compositions. In particular, we focused on the importance of
cholesterol (Chol), sincemembrane rafts are a key structure in the extrin-
sic pathway of apoptosis [13]. In fact, the apoptotic effects of cytotoxic BAs
were suppressed upon Chol depletion andDCAhas been shown to induce
a signiﬁcant change in both concentration and distribution of Chol in the
plasma membrane of living cells [14,15]. UDCA, a cytoprotective BA, on
the other hand, did not exhibit this effect, suggesting that BAs might
have different effects on lipid membranes depending on their molecular
properties [14]. Also, given the inﬂuence of cytotoxic BAs on death recep-
tor activation in the plasma membrane [2], BA-induced apoptosis could
be the effect of alterations on plasma membrane structure.
The objective of this work was to determine if cytotoxic or cyto-
protective BAs, at physiologically active concentrations, were able to
modulate the biophysical properties of lipid membranes to an extent
which could translate into changes in the apoptotic propensity of cells.Fig. 1. Structure of ﬂuorescence analogues of DCA and UDCA and ﬂuorescence spectra in
buffer. (A) NBD-derivatized deoxycholic acid (DCA-NBD - top) and NBD-derivatized
ursodeoxycholic acid (UDCA-NBD - bottom). (B) Fluorescence emission and excitation spec-
tra from DCA-NBD and UDCA-NBD in HEPES buffer. Fluorescence excitation spectra
(dashed), were measured at an emission wavelength of 540 nm. Fluorescence emission
spectra (full), were obtained at an excitation wavelength of 460 nm. Spectra were normal-
ized to the value at maximum intensity.Twoputativemechanisms for the cytoprotective role ofmore hydrophilic
BAs were studied here: i) cytoprotective BAs could disrupt partition of
cytotoxic BAs to lipidmembranes and ii) changes in the biophysical prop-
erties of lipid membranes induced by cytoprotective BAs could oppose
changes induced by cytotoxic BAs. Any of these mechanisms could
potentially result in a prevention of membrane compromise, leading to
cell survival. Here, DCA and CDCA were used as models for cytotoxic
BAs, and both UDCA and TUDCA were used as models for cytoprotective
BAs. In order to characterize differences in lipid membrane binding
properties for the two classes of BAs, nitro-2-1,3-benzoxadiazol-4yl
(NBD) ﬂuorescent derivatives DCA-NBD and UDCA-NBD were synthe-
sized (Fig. 1A). Model membranes were used throughout this study in
order to characterize the effects of BA in different lipid compositions,
namely in the presence or absence of liquid ordered (lo), raft-like,
membranes.
In this study, we show that while cytotoxic BAs display a higher
afﬁnity for lipid membranes than the cytoprotective molecules, both
classes of BAs have higher afﬁnity for liquid disordered (ld) membranes
than for lo. All BAs studied are found to have limited insertion in the
lipid membrane upon binding, i.e., a more superﬁcial location in the
bilayer. Additionally, cytoprotective BAs are shown to have no effect
on cytotoxic BA interaction with lipid membranes. Importantly, the
cytotoxic BAs DCA and CDCA are found to prevent the rigidiﬁcation of
lipid membranes induced by Chol and to signiﬁcantly expand mem-
brane surface area. These effects are not associated with the removal
of Chol from the membrane. On the other hand, cytoprotective BAs at
physiologically active concentrations had no effect on membrane
properties.
From the absence of effects of cytoprotective BAs on the properties
of lipid membranes, we conclude that the cytoprotective properties of
these molecules are not associated withmodulation of lipid membrane
structure. On the other hand, given the observed signiﬁcant effects of
cytotoxic BAs on membrane rigidity, it is concluded that the apoptotic
activity of these molecules could potentially be associated with changes
in plasmamembrane organization, e.g. raft formation, orwith an increase
in mitochondrial membrane afﬁnity for speciﬁc apoptotic proteins.
2. Materials and methods
2.1. Materials
1-Palmitoyl-2-oleoyl-sn-glicero-3-phosphocholine (POPC), N-
palmitoyl-D-erythro-sphingosylphosphorylcholine (PSM) and 1,2-
dipalmitoyl-sn-glycero-3-phosphoethanolamine-N-biotinyl (DPPE-
biotin) were purchased from Avanti Polar Lipids (Alabaster, AL, USA)
and Chol was from Sigma-Aldrich (St. Louis MO, USA). All lipids were
kept in Uvasol grade chloroform (Sigma-Aldrich). Unlabeled DCA, CDCA
and TUDCA in sodium salt form, HEPES, NaCl and Avidinwere purchased
from Sigma-Aldrich. UDCA sodium salt was purchased from Santa Cruz
Biotechnologies (Santa Cruz, CA).
1,6-Diphenyl-1,3,5-hexatriene (DPH), 1-(4-trimethylammonium-
phenyl)-6-phenyl-1,3,5-hexatriene p-toluenesulfonate (TMA-DPH) and
1-[2-hydroxy-3-(N,N-di-methyl-N-hydroxyethyl)ammoniopropyl]-
4-[β-[2-(di-n-butylamino)-6-napthyl] vinyl]pyridinium dibromide
(di-4-ANEPPDHQ) were purchased from Invitrogen (Carlsbad, CA, USA).
1,2-Dioleoyl-sn-glycero-3-phosphoethanolamine-N-(lissamine rho-
damine B sulfonyl) (DOPE-Rho) and 1,2-dipalmitoyl-sn-glycero-
3phosphoethanolamine-N-(7-nitro-2-1,3-benzoxa.diazol-4yl) (DPPE-
NBD) were obtained from Avanti Polar Lipids. Dehydroergosterol
(DHE) was from Sigma-Aldrich. All ﬂuorescent probes were kept in
UVasol-grade solvents at−26 °C.
2.2. Synthesis of ﬂuorescent derivatives of BAs
All reagents were acquired from Sigma-Aldrich, 1H-NMR spectra
were recorded on a Bruker 400 Ultra-Shield Spectrometer, and Mass
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with ESI+/− source.
DCA-NBD:
a) Synthesis of theﬂuorophorewith diamine linker, NBD-NH(CH2)3NH2.
To a solution of 4-chloro-7-nitro-1,2,3-benzoxadiazole (NBD-Cl,
100 mg, 0.5 mmol) in DMF (5 mL) was added 1,3-propanediamine
dropwise (42 μL, 0.5 mmol). The reaction mixture was stirred at
room temperature for 30 min, concentrated in vacuum and the
product isolated by precipitation from DMF/diethyl ether, leading
to the desired ﬂuorophore with the attached linker in 82% yield
(97 mg). 1H-NMR (MeOD) δ (ppm): 2.12 (br t, 2H, NH2), 2.73,
2.89, 3.62 (3×br s, 6H, 3CH2), 6.43 (d, 1H, NBD), 7.95 (s, 1H, NH),
8.50 (br d, 1H, NBD).
b) The amino acid coupling reaction was performed by activating DCA
(100 mg, 0.24 mmol), using TBTU (93 mg, 0.29 mmol) as coupling
agent in DMF (5 mL), in the presence of diisopropylamine (51 μL,
0.29 mmol) at room temperature. Then, NBD-NH(CH2)3NH2 (69 mg,
29 mmol) was added and the reaction mixture was stirred at room
temperature for 24 h. The mixture was poured into water and
extracted with EtOAc (3×), the organics were combined, dried over
Na2SO4, ﬁltered and concentrated in vacuum. The target compound
was puriﬁed by silica-gel column chromatography with n-Hex/
EtOAc (1:9) to 100% EtOAc and ﬁnally EtOAc/MeOH (9:1) to afford
the desired DCA-NBD (55 mg, 9 mmol, 32%) as a red powder.
MS(ESI+): 634.24 [M + Na]+. MS(ESI−): 610.34 [M − H]−.
1H-NMR (MeOD) δ (ppm): 0.66 (s, 3H, CH3), 0.93 (s, 3H, CH3),
1.03 (d, 3H, J = 6.3 Hz, CH3), 1.14–2.01 (m, 33 H), 2.10–2.32 (2H),
3.51–3.63 (m, 2H), 3.94 (br s, 1H), 6.36, 8.53 (2d, 2H, J = 8.8 Hz,
NBD).
UDCA-NBD:
In this case a one-pot procedure was applied. To a solution of UDCA
(20.4 mg, 0.05 mmol) in DMF (1 mL) at room temperature was
added diisopropylamine (10.5 μL, 0.06 mmol) and TBTU (18 mg,
0.06 mmol) and the activation proceeded for 30 min. Then,
1,3-propanediamine (10 μL, 0.12 mmol) was added and the reac-
tion was followed by TLC. After 2 h, NBD-Cl (22 mg, 0.12 mmol)
was added and the reaction stirred at 40 °C for 24 h. The mixture
was poured into water and extracted with EtOAc (3×), the organics
were combined, dried over Na2SO4, ﬁltered and concentrated in
vacuum. The target compound was puriﬁed by silica-gel column
chromatography with n-Hex/EtOAc (1:9) to 100% EtOAc and ﬁnally
EtOAc/MeOH (9:1). UDCA-NBD was further puriﬁed by preparative
TLC using EtOAc as eluent to afford the pure desired UDCA-NBD
(14.3 mg, 45%) as a red powder. MS(ESI+): 634.24 [M + Na]+.
MS(ESI−): 610.29 [M − H]−. 1H-NMR (MeOD) δ (ppm): 0.57 (s,
3H, CH3), 0.77–2.19 (m, 41 H), 3.38–3.54 (m, 2H), 4.12 (d, 1H),
6.26, 8.43 (2d, 2H, J = 8.9 Hz, NBD).
2.3. Lipid vesicle preparation
Required volumes of lipid and ﬂuorescent probe stock solutions
were mixed in chloroform and dried under a ﬂow of dry nitrogen gas
(N2). Last traces of solvent were removed overnight under vacuum.
Multilamellar vesicles were obtained through hydration inHEPES buffer
(10 mM HEPES, 150 mM NaCl at pH 7.4, prepared in Milli-Q water)
followed by freeze–thaw cycles. Large unilamellar vesicles (LUVs)
were produced by extrusion through polycarbonate ﬁlters with a pore
size of 100 nm (Whatman, USA) on a mini-extruder (Avanti Polar
Lipids). LUVs were kept at room temperature and in the dark until
being used, at most for 48 h after being prepared.
Giant unilamellar vesicles (GUVs) [16,17] were prepared by mixing
the required volumes of lipid and ﬂuorescent probe stock solutions inchloroform to a ﬁnal lipid concentration of 1 mM. This mixture was
supplemented with 1 nM of biotinylated lipid DPPE-biotin. 4 μL of this
solution were spread over the faces of a pair of platinum electrodes,
which were then dried in vacuum. Electrodes were immersed in a
pre-heated 200 mM sucrose solution, and connected to signal genera-
tor for 1 h and 15 min. Electroformation occurred at a temperature
over themelting temperature of the lipidwith the highestmelting tem-
perature in the lipid mixture [18]. Imaging of GUVs was performed on
μ-Slide from Ibidi (Munich, Germany). Immobilization of GUVs was
achieved with DPPE-biotin as previously described [19].
For the formation of all model membrane systems, the required
amounts of POPC, Chol and PSM used were taken from the phase
diagram for this ternary system [20]. POPC and PSM concentrations
were determined by phosphorous analysis [21] and Chol concentration
was determined gravimetrically. Concentration of ﬂuorescent probes
was determined spectrophotometrically from absorbance data using
ε(NBD, 465 nm, methanol) = 21 × 103 M−1 cm−1 [22], ε(DOPE-Rho,
559 nm, chloroform) = 95 × 103 M−1 cm−1 [22], ε(DPH, 355 nm,
chloroform) = 80.6 × 103 M−1 cm−1 [23], ε(TMA-DPH, 355 nm,
chloroform) = 52 × 103 M−1 cm−1 [24], ε(di-4-ANEPPDHQ, 460 nm,
chloroform) = 36 × 103 M−1 cm−1 [22], and ε(DHE, 328 nm, etha-
nol) = 36 × 103 M−1 cm−1 [25].2.4. Steady-state ﬂuorescence spectroscopy
Fluorescence steady-state measurements were performed in a
SLM-Aminco 8110 Series 2 spectroﬂuorometer (Rochester, NY) with
double excitation and emission monochromators (MC-400, Rochester,
NY), in right-angle geometry. Light source was a 450-watt Xe arc
lamp and the reference was a Rhodamine B quantum counter solution.
Temperature was controlled by a thermostated cuvette holder (Julabo
F25, Houston, TX, USA) and magnetic stirring was used. Polarization of
excitation and emission light was achieved using Glan–Thompson
polarizers. Both 1 cm × 1 cm and 0.5 cm × 0.5 cm Hellma quartz
cuvettes were used in this study. Fluorescence intensities are calculated
through integration of the obtained emission spectra. Background ﬂuo-
rescence intensity was subtracted using a solution containing either
unlabeled vesicles and/or unlabeled bile acids. Excitation and emission
spectra were corrected for different instrumental response, due to
inherent lamp and monochromator characteristics, as well as
wavelength-dependent photomultiplier sensitivity.2.5. Transient-state ﬂuorescence spectroscopy
Fluorescence decayswere obtainedwith the Time-Correlated Single-
Photon Timing technique (TCSPT). Excitation pulseswere produced by a
Ti-Sapphire solid state laser system (460 nm) or a frequency-doubled
cavity-dumped dye laser of DCM (Coherent 701-2) (340 nm). Emission
wavelengths were selected using a Jobin Yvon HR320 monochromator
(Horiba Jobin Yvon Inc.). The excitation pulse proﬁle was obtained
using a scattering Ludox mixture, an aqueous solution of colloidal silica
(Sigma-Aldrich). Decay curves were stored in 1024 channels and the
used time-scale varied according to experimental conditions, from
9.76 to 48.8 ps/ch. The number of counts in the peak channels of the
sample decay and instrumental response function were 20,000 and
50,000, respectively. 0.5 cm × 0.5 cm Hellma quartz cuvettes were
used and samples were always under magnetic stirring. All measure-
ments were performed at room temperature. Decay curves were
analyzedwith TRFA (version 1.4) from Scientiﬁc Software Technologies
Centre (Belarusian State University). Quality of the ﬁts was judged
based on χ2 value, weighted residuals and autocorrelation plots.
The ﬂuorescence decays obtained in this study were always multi-
exponential. In this way, ﬂuorescence decays were characterized by
the amplitude-weighted lifetime, τ , as deﬁned elsewhere [26].
Fig. 2. Partition of ﬂuorescent labeled BAs to ld and lo membranes. Liposomes
were composed of only POPC (A) or were formed using 25:35:40 POPC:Chol:
PSM (%mol/%mol/%mol) (100% lo phase, B). Fluorescence intensity values were nor-
malized to the value at [POPC] = 0 μM. Experimental data is displayed as black squares
(DCA-NBD) and gray triangles (UDCA-NBD). Curves are ﬁts of Eq. (1) to experimental
data. Recovered KP values were 53.9 × 103 and 9.7 × 103 for DCA-NBD to ld and lo vesicles,
respectively. For UDCA-NBD, recovered KP values were 40.9 × 103 and 4.5 × 103 to ld and lo
vesicles, respectively. Labeled BAs were excited at 460 nm. Fluorescence emission spectra
were measured between 480 and 700 nm (λexc = 460 nm). Labeled BA concentration
was 2 μM.
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All measurements were performed on a Leica TCS SP5 (Leica
Microsystems CMS GmbH, Manheim, Germany) inverted confocal
microscope (DMI6000). Excitation lines provided by an argon laser
were focused into the sample by an apochromatic water immersion
objective (63×, NA 1.2; Zeiss, JenaGermany). A 111.4 μmdiameter pin-
hole in front of the image plane blocked out-of-focus signals. DCA-NBD,
UDCA-NBD or DPPE-NBD were excited at 458 nm and emission was
collected between 480 and 570 nm. DOPE-Rho was excited at 514 nm
andemissionwas collected between 570 and620 nm.XY slices separated
by 0.4 μm along the z-axis were obtained and 2D maximum intensity
projections were constructed using the maximum intensity projection
method. Every slice was acquired in two different channels using the
excitation and emission described above. Images were treated with
ImageJ software (Wayne Rasband NIH, USA).
For the determination of the membrane fraction in the ld phase on
GUVs through imaging, two maximum intensity projections of each
GUV were obtained for both hemispheres. The area of ld phase on
both hemispheres was determined from DOPE-Rho enriched domains,
while total GUV area was obtained from DPPE-NBD ﬂuorescence
intensity.
2.7. Partition coefﬁcient determination
Partition coefﬁcient (KP) values for membrane/water partition
allow a quantiﬁed evaluation of the afﬁnity of a particular molecule
for lipid membranes. In order to obtain KP's of labeled BAs to lipid
membranes, the following equations were ﬁtted to the ﬂuorescence
data [27]:
I ¼ Iw þ KpγL L½ IL
1þ KpγL L½ 
ð1Þ
τ ¼ τw þ KpγL L½ τL
1þ KpγL L½ 
ð2Þ
where Iw or τw and IL or τL are probe ﬂuorescence intensity or
amplitude-weighted ﬂuorescence lifetime in solution or in the lipid
membrane, respectively; KP is the partition coefﬁcient and γL is lipid
molar volume. A γL = 0.75 dm3 mol−1 was used [28]. Iw or τw are
the ﬂuorescence intensity or amplitude-weighted ﬂuorescence lifetime
obtained in the absence of lipid. IL orτL and KPwere optimized using the
least-square method with Origin8 (OriginLab, Northampton, MA, USA).
2.8. FRET studies
FRET efﬁciencies were calculated from changes in steady-state
ﬂuorescence intensity, I, or donor lifetime, τ [26]:
E ¼ 1− IDA
ID
¼ 1− τDA
τD
ð3Þ
where the D and DA indexes represent donor alone or donor in the
presence of the acceptor, respectively.
3. Results
3.1. Partition of labeled BAs to model membranes
Fluorescence emission and excitation spectra in aqueous solution
were obtained for the two labeled BAs, DCA-NBD and UDCA-NBD
and both labeled BAs presented identical excitation and emission
spectra in buffer (Fig. 1). When unlabeled BAs were added to
derivatized BAs in buffer, the ﬂuorescence quantum yields of both
DCA-NBD and UDCA-NBD was heavily dependent on unlabeled BAconcentration in themillimolar regime, conﬁrming that the derivatives
readily incorporated in the micellar structures of BAs (Supplemental
Fig. I). Concomitant emission blue-shifts were observed (Δλ = 12 nm),
pointing out to a less polar environment [29].
In fact, the ﬂuorescence from BA derivatives was more sensitive to
the formation of unlabeled BA micelles than the ﬂuorescence of Nile
Red (Supplemental Fig. I), a ﬂuorescent probe often used for spectro-
photometric characterization of micelle formation by amphiphiles
[30]. This indicates that labeling does not disrupt the self-aggregating
properties of BAs, and that the derivatives are good mimics of BAs in
solution.
Having established that derivatization did not disrupt the amphi-
philic properties of BAs, these molecules were employed in the charac-
terization and quantiﬁcation of BA partition to model lipid membranes
with different compositions. The afﬁnity for lipidmembranes is of great
relevance in determining the pharmacological effects of a number of
drugs [31]. In order to quantify membrane partition afﬁnity of ﬂuores-
cently labeled BAs, three systems were used for determination of parti-
tion coefﬁcients (KP, Eqs. (1) and (2)). Firstly, partition to ld vesicles
(without Chol) was assessed; then partition to lo-only vesicles
(Chol-rich) was quantiﬁed. To complement the aforementioned
Table 1
Partition coefﬁcients, ﬂuorescence lifetimes and steady-state anisotropies of labeled
BAs in ld and lo membranes.
Labeled BA Lipid phase KP (103) KP(ld,lo) br>L τ L (ns)
DCA-NBD ld 53.9 ± 7.7 5.5 ± 1.0 0.15 5.4
lo 9.7 ± 1.1 0.14 –
UDCA-NBD ld 40.9 ± 6.3 9.1 ± 2.2 0.14 5.3
lo 4.5 ± 0.8 0.16 –
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phase coexistence was conducted. The analysis of probe partition to
these model lipid systems, ld and lo liposomes, is of great biological rel-
evance since these systems mimic non-raft and raft-like domains,
respectively.
Labeled BAs were added to the lipid vesicles and left to incubate for
30 min afterwhich labeled BA ﬂuorescence intensitywasmeasured as a
function of liposome concentration. Labeled BA ﬂuorescence intensity
increased as a function of lipid concentration for the two labeled BAs
in both lipid compositions (Fig. 2). This was accompanied by a blue-
shift (Δλ = 14 nm), in the emission spectra of both probes (Supple-
mental Fig. II). No excitonic interactions and formation of ground-state
NBD complexes are observed [32]. KP values were recovered from ﬂuo-
rescence intensity curves through ﬁtting Eq. (1) to the data. Recovered
partition coefﬁcients were larger for DCA-NBD than for UDCA-NBD in
both lipid systems, conﬁrming that the more hydrophobic bile acid
has signiﬁcantly more afﬁnity for lipid membranes (Table 1). The ﬂuo-
rescence anisotropy decays at the highest lipid concentration were sig-
niﬁcantly different from anisotropy decays obtained in the absence of
liposomes (Supplemental Figure III). Namely, the ﬂuorophores did not
depolarize completely, hinting that its motion was hindered by the
membrane,moving only in a restricted angular volume. These dynamics
were analyzed according to the wobbling-in-cone model, which con-
siders that hindered ﬂuorophore rotation is limited by the walls of a
cone of semiangle θ [33]. Using this model to analyze the results from
DCA- and UDCA-NBD, recovered cone angles were identical, θ = 63°
and 64°, respectively (Supplemental Table I), and suggested that both
molecules were present at a very similar location within the lipid mem-
branes. Additionally, and comparing to published values of NBD cone
semiangles for rotation (36–53°) obtained for a phospholipid anchored
NBD (DPPE-NBD) also in ld bilayers [34], it can be concluded that the
labeledBAs are still highlymobile uponmembrane binding. This suggests
that the molecules are possibly not anchored within the acyl-chains,
since this would result in signiﬁcantly lower rotational dynamics as
seen for DPPE-NBD. These values can be compared since the average
ﬂuorescence lifetimes obtained for DCA-NBD and UDCA-NBD are
almost identical to that of DPPE-NBD in the reportedwork (Supplemental
Table I) [34].
With the previously recovered partition coefﬁcients, a KP(ld,lo) can
be calculated (Eq. (4)). This reﬂects the relative afﬁnity of labeled BAs
to the non-raft and raft-like lipid membrane phases. For this calculation
it was assumed that labeled BAs partition equally to a POPC-only-ld
phase and a POPC:Chol:SM-ld phase.
KP ld; loð Þ ¼
KP ldð Þ
KP loð Þ
: ð4Þ
The obtained KP(ld,lo), of 9.1 for UDCA-NBD and 5.5 for DCA-NBD,
showed that in the presence of non-raft and raft-like lipid domain
coexistence (as in a cellular membrane), labeled BAs would preferably
partition to the non-raft phase (Table 1). This result is consistent with
a previous report, that high Chol levels reduced the binding afﬁnity of
taurine-conjugated BAs and that incorporation of cytotoxic BAs was
less sensitive to Chol [35].
Interestingly, the ﬂuorescence anisotropy of both labeled BAs in the
lipid membrane was similar for both ld and lo membrane phases(Table 1). The lo phase is characterized by a lower degree of acyl-chain
dynamics than the ld phase. As such, lo membranes have higher rigidity
than ldmembranes. However, the rotational dynamics of theNBDgroup,
for both derivatized BAs, is insensitive to rigidity of the phase they are
partitioning to. Once more, this indicates that labeled BAs are not
strongly anchored to the membrane, and that adsorption to the lipid/
water interface, with limited insertion in the membrane interior, is
more likely to occur.
Partition of labeled BAs to raft-like and non-raftmodel membranes
was also studied by confocal microscopy. In this experiment, GUVswith
ld/lo phase coexistence were electroformed. DOPE-Rho was used in
trace amounts (1/500 probe lipid ration) to label the ld phase within
theGUVs, since the unsaturated chains of this labeled phospholipid pre-
vent partition to more ordered membranes [36]. GUV z-stack images
were obtained in the confocal microscope to construct 2D maximum
intensity projections of eachhemisphere. Once again, a clear ld preference
was observed as the signal from the NBD-labeled BAs co-localized with
the signal from DOPE-Rho (Fig. 3). It should be stressed that microscopy
data does not allow a direct determination of a quantiﬁed partition
coefﬁcient, given the uncertainties in quantum yield for each phase.
To test for an inﬂuence of cytoprotective BAs on the partition of
their cytotoxic counterparts, DCA-NBD partition to POPC vesicles was
assessed after vesicles were incubated overnight with 10 and 100 μM
of hydrophilic BAs. 2 μM of DCA-NBD were then added to the vesicles
and DCA-NBD partition was determined from the ﬂuorescence lifetime
variation (Eq. (2)). DCA-NBD partition seemed to be unaffected by
previous vesicle incubation with hydrophilic BAs as ﬂuorescence life-
time partition curves obtained were independent of hydrophilic BA
concentration (Fig. 4A, C). Also, anisotropy decays obtained using the
highest POPC concentration were independent of the concentration of
cytoprotective BAs (Fig. 4B, D). These results clearly prove that neither
UDCA nor TUDCA have any effect on DCA-NBD partition to lipid
membranes.
In summary, DCA-NBD displays a higher afﬁnity for lipid mem-
branes thanUDCA-NBD,while both labeled bile acids exhibit preference
for ld (non-raft) over lo (raft) lipid phase. Also, the high mobility of
labeled bile acids after binding to lipid membranes in both ld or lo
phases, suggest that bile acids are not strongly anchored in the lipid
bilayer, and are likely to have a superﬁcial location at the lipid/water
interface.
3.2. Bile acid modulation of membrane properties
Following the characterization of the association of cytotoxic and
cytoprotective BAs with lipid membranes, the effect of BA binding
on the biophysical properties of model lipid membranes was studied.
To achieve this, the effects of BA incubation on the ﬂuorescence signal
of three different membranes probes, DPH, TMA-DPH and di-4-
ANEPPDHQ, was studied.
DPH and TMA-DPH are widely used to report membrane ﬂuidity
[20,24] through ﬂuorescence anisotropy, while di-4-ANEPPDHQ ﬂuo-
rescence is sensitive to membrane potential [37,38]. Overall, their
ﬂuorescence signal is extremely sensitive to membrane composition
and order. DPH is an inner membrane probe, displaying a highly buried
location on lipid membranes [39]. On the other hand, TMA-DPH and
di-4-ANEPPDHQ, are more superﬁcially located on membranes due to
the presence of a charged group on their structures [39,40].
Unlabeled BAs were cosolubilized with the lipid components of the
system, containing either DPH, TMA-DPH or di-4-ANEPPDHQ. DPH
and TMA-DPH ﬂuorescence anisotropies and di-4-ANEPPDHQ ﬂuores-
cence intensities were measured as a function of BA concentration.
DPH anisotropy was insensitive to all BAs (Supplemental Fig. IVA).
However, TMA-DPH ﬂuorescence anisotropy increased signiﬁcantly
when BAs were cosolubilized with the liposomes (Supplemental
Fig. IVB). The same being observed for di-4-ANEPPDHQ ﬂuorescence
intensity in the presence of DCA (Supplemental Fig. IVC). Insensitivity
Fig. 3. Partition of ﬂuorescent labeled BAs to ld domains in GUVs under ld/lo phase coexistence. GUVs, composed of POPC:Chol:PSM 33:33:33 (%mol/%mol/%mol), displaying ld/lo
phase coexistence, were labeled with DOPE-Rho at a ratio of 1/500. Fluorescence from Rho (red) and NBD (green) channel was sequentially collected, and projections for GUV
hemisphere are shown for GUVs in the absence of labeled BAs (A), or in the presence of 20 μM of DCA-NBD (B) and UDCA-NBD (C). Only ld domains are visible since neither
DOPE-Rho or BA-NBD partitioned to the lo phase. Lines are drawn to describe the shape of GUVs.
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that although signiﬁcant BA binding to the liposomes takes place, acyl
chain ﬂuidity remains unaltered, likely because BAs are only found near
the membrane surface, with very limited insertion in the hydrocarbon
environment, as previously observed for ﬂuorescent labeled BAs. This is
in agreement with results obtained with ﬂuorescent analogs of BAs.
Interestingly, when BAs were added to preformed liposomes at
100 μM, no changes were observed, in the ﬂuorescence signal of all
membrane probes used (Supplemental Fig. IV). Possibly, this phenom-
enon is associated with stable BA aggregation in buffer at submillimolar
concentration, which is not observed upon cosolubilization with mem-
brane components. In this case, partition behavior of preformed BA
aggregates would differ from monomeric BA partition, resulting in
decreased BA interaction with membranes. It is highly likely that in
vivo, given the presence of high concentrations of possible protein bind-
ing partners for BAs in the medium, the stability of BA premicellar
aggregates is signiﬁcantly lowered, and the interaction with mem-
branes is more effective.
Since partition of BAs to preformed liposomes in vitro is limited by
aggregation of the molecules before membrane interaction, higher
concentrations of BAs were used to probe for modulation of membrane
biophysical properties on preformed membranes. In this way, 500 μM
of unlabeled BAs were added to preformed liposomes labeled with
di-4-ANEPPDHQ and its ﬂuorescence lifetime was measured. This con-
centration is still well below the critical micellar concentration for the
BAs studied here; nevertheless, a control was performed for membrane
solubilization. In this control, DPH-labeled liposomes were subjected to
identical BA concentrations and incubation times as di-4-ANEPPDHQ li-
posomes. DPH ﬂuorescence anisotropy was only marginally affected inthe presence of 500 μMBA (Fig. 5B). The decrease cannot be associated
with vesicle solubilization as DPH ﬂuorescence anisotropy remain at
values typically observed for lipid membranes (0.10–0.12) [36,41,42],
while DPH anisotropy in micelles is signiﬁcantly lower [43]. In fact,
the small decrease in DPH anisotropy can be rationalized on the basis
of its longer lifetime (Supplemental Fig. V). This would allow for a
slightly longer depolarization time and lower anisotropy [26].
Semiangles for rotation recovered from anisotropy decays of DPH
according to thewobbling-in-conemodel [33] also remained unchanged
(Fig. 7D). Overall these results clearly indicate that liposomes are not
solubilized after incubation with 500 μM BA.
On the other hand, di-4-ANEPPDHQ ﬂuorescence lifetime increased
signiﬁcantly when POPC liposomes were incubated with both cytotoxic
and cytoprotective BAs (Fig. 5A). The increase was greater for cytotoxic
bile acids, in agreement with our previous results obtained through
cosolubilization of BAs (Supplemental Fig. IVC). However, both hydro-
philic BAs also increased the membrane probe ﬂuorescence lifetime to
some extent.
Since cytotoxic and cytoprotective BAs affected ﬂuorescence life-
times of di-4-ANEPPDHQ to a different extent, co-incubation of POPC
liposomeswith hydrophilic BA + DCA(500 + 500 μM)wasperformed
by adding cytoprotective BAs and DCA simultaneously. In this experi-
ment, interference of cytoprotective BAs on the effects of the cytotoxic
BA (DCA) on the biophysical properties of model membranes were
probed. Di-4-ANEPPDHQ ﬂuorescence lifetime increased in a cumula-
tive manner (Fig. 5A). After co-incubations, differences in ﬂuorescence
lifetimes were equivalent to the sum of the effects of DCA plus the
cytoprotective BA used (Fig. 5A). In this way, cytoprotective BAs do
not prevent DCA-induced changes on di-4-ANEPPDHQ ﬂuorescence.
Fig. 4. Cytoprotective BAs have no inﬂuence on the partition of DCA-NBD to lipid membranes. Amplitude-weighted ﬂuorescence lifetimes (τ) of DCA-NBD are shown as a function of
[POPC] for different concentrations of cytoprotective BAs (symbols in A and C). Eq. (2) was ﬁtted to the data and ﬁtted curves are shown (in A and C). Fluorescence anisotropy
decays of DCA-NBD were obtained at the highest POPC concentration employed in the partition experiment (B, D). Transient state ﬂuorescence data was acquired at 340 nm
wavelength for excitation and 540 nm wavelength for emission. DCA-NBD concentration was always 2 μM.
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cence are cumulative, support the results obtained with ﬂuorescent
labeled BAs, which indicated that the presence of cytoprotective BAs
had no effect on the binding of cytotoxic BAs to the membrane. Since
BAs were unable to induce membrane solubilization at 500 μM, the
increase in ﬂuorescence lifetime observed for di-4-ANEPPDHQ was
probably associated with a decrease in membrane hydration due to
high levels of BA partition.
In summary, in POPC vesicles, the membrane surface ﬂuorescent
probes TMA-DPH and di-4-ANEPPDHQ were clearly sensitive to incu-
bation with BAs, particularly cytotoxic BAs. In contrast, the probe for
acyl-chains dynamics, DPH, was almost insensitive to the presence of
all BAs, conﬁrming that BA's are not deeply inserted in the membrane,
and also that no membrane solubilization takes place at submillimolar
BA concentrations. In this way, results obtained with labeled BAs on
the location within bilayer are in full agreement with data obtained
with unlabeled BAs. Overall, the results strongly indicate that BAs
present a very limited insertion within the lipid bilayer after liposome
binding.3.3. BA effects on Chol-containing membranes
The role of Chol in the interaction between BAs and lipid mem-
branes has been dealt with in previous studies. In some cases, BAs
and Chol were proposed to compete for the same position in the
membrane [35,44], while others claimed that BAs depend on mem-
brane Chol to exert their role in vivo [14].Here, the effect of BAs on membrane biophysical properties was
assessed using several mixtures of POPC:Chol. DPH was used to label
liposomes and its ﬂuorescence steady-state anisotropy was measured
as a function of Chol concentration. In this study, BAs were once more
added to preformed liposomes.
As Chol content increases, DPH anisotropy values also increase, as a
result of tighter packing of lipids in the membrane (Fig. 6A). Liposome
incubation with either UDCA or TUDCA did not induce any change in
DPH anisotropy (Fig. 6A). However, when the cytotoxic BAs DCA or
CDCA were added, DPH anisotropy decreased signiﬁcantly (Fig. 6A).
Membrane ﬂuidity was only sensitive to cytotoxic BAs when Chol was
present. At 40% Chol, the effect of DCA decreased signiﬁcantly, and
DPH anisotropy values after incubation with the BA, approached the
values obtained for the control. In this way, considering that the latter
composition generates lipid membranes close to 100% in the lo phase,
DCAwas apparently inert for lo membranes but inhibited the rigidifying
effect of Chol in ld phases. This effect is not associatedwith a decrease in
lo domain formation, as it was observed at Chol concentrations for
which the lo phase is not present (5 and 10% Chol) [20]. Additionally,
co-incubation of vesicleswith UDCAor TUDCAplusDCA did not prevent
the effect of DCA (Fig. 6B). On the other hand, the effect of CDCA incuba-
tion on membrane ﬂuidity at 40% Chol was higher than the effect
observed for DCA (Fig. 6A).
In order to test if the inhibition of the Chol rigidifying effect onmem-
branes by cytotoxic BAswas a result of Chol removal, a ﬂuorescent Chol
analog, DHEwas used [45–47]. Unlike other ﬂuorescent sterols [48], the
behavior of this molecule in lipid membranes presents great similarity
to Chol [47]. POPC liposomes labeled with DHE were incubated
Fig. 5. BAs have limited insertion on the membrane interior after binding to liposomes.
(A) 500 μM of BAs were incubated overnight with di-4-ANEPPDHQ-labeled liposomes.
Amplitude-weighted ﬂuorescence lifetimes (τ) of di-4-ANEPPDHQ were obtained at
460 nm excitation and emission set to 590 nm. (B) 100 or 500 μM of DCA, UDCA or
TUDCA were added to POPC liposomes loaded with DPH and incubated overnight. DPH
was excited at 340 nm and ﬂuorescence anisotropy was recovered at 430 nm. Probe/
lipid ratio used was always 1/200.
Fig. 6. Cytotoxic BAs inhibit the rigidifying effect of Chol on model membranes. DPH
ﬂuorescence anisotropy is shown as a function of Chol concentration for different
BAs incubated overnight with POPC:Chol liposomes. Liposomes labeled with DPH
were incubated overnight with BAs (A), or with 500 μM of cytoprotective BA followed
by 8 h of incubation with 500 μM DCA (B). DHE ﬂuorescence intensity was measured on
liposomes in the presence and absence of 500 μM BA, following an overnight incubation
(C). DHE was also incubated overnight with a 500 μM DCA solution in the absence of
liposomes. DHE was excited at 280 nm and ﬂuorescence intensity measured at 320 nm.
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the absence of liposomes) was also added to 500 μM of DCA, in the ab-
sence of liposomes, in order to register the signal for complete DHE re-
moval. DHE ﬂuorescence in 500 μM of DCA in the absence of liposomes
was nearly 10% of its value in vesicles, indicating that removal could be
followed by intensity variations (Fig. 6C). However, when BAs were
added to membranes, no loss in ﬂuorescence intensity was observed.
Clearly, BAs at submillimolar concentrations are unable to remove
DHE from liposomes, which indicated that cytotoxic BAs are not acting
through the removal of membrane Chol.
A decrease in DPH ﬂuorescence anisotropy induced by cytotoxic BAs
could also be caused by an increase in the lifetime of the probe. With
this in mind, both ﬂuorescence intensity and ﬂuorescence anisotropy
decays of DPH were obtained from liposomes with 0, 20 and 40% Chol
after incubation with 500 μM of cytotoxic BAs. DPH mean ﬂuorescence
lifetime was not affected by cytotoxic BA incubation in the presence of
Chol (Supplemental Fig. VA). However, both DCA and CDCA were no-
ticeably interfering with the rotational dynamics of DPH, signiﬁcantly
affecting the anisotropy decay of DPH (Fig. 7). The ﬂuorescence anisot-
ropy decay of DPH with 20% Chol and 500 μMDCA or CDCA (Fig. 7B, C)
was almost identical to the decay obtained with 0% Chol in the absence
of BA incubation (Fig. 7A). This effect translates into changes in rotation
cone semiangles according to thewobbling-in-conemodel (Fig. 7D) [33].
Cone angles for DPH were nearly insensitive to cytotoxic BAs in the ab-
sence of Chol. In the presence of Chol, incubation with cytotoxic BAs
resulted in an increase in the wobbling-in-cone semiangle (increase in
DPH mobility). At 40% Chol, close to 100% lo phase, the effect of DCAwas almost completely abolished, while CDCA was slightly more effec-
tive in decreasing membrane ﬂuidity for this lipid composition.
The effect of cytotoxic BAs on Chol-containing membranes was also
observed in a more complex raft mimickingmixture (POPC:PSM:Chol).
The lipid components in this mixture are representative of the most
common plasma membrane lipid components. Initially, the effects of
cytotoxic BAs on the membrane ﬂuidity of a lipid bilayer composed of
POPC:PSM:Chol (71.6:5:23.3 mol%:mol%:mol%) were evaluated. This
lipidmixtures results in the formation of 100% ld phase at room temper-
ature [20]. In this case, incubation of lipid bilayers with cytotoxic BAs
Fig. 7. Cytotoxic BAs increase DPH mobility in Chol-containing liposomes. Fluorescence anisotropy decays of DPH in POPC:Chol liposomes with different Chol concentrations in the
absence (A), or presence of 500 μM of DCA (B) or CDCA (C), following an overnight incubation with the cytotoxic BAs. DPH was excited at 340 nm and ﬂuorescence anisotropy was
recovered at 430 nm. (D) Semiangles of DPH mobility cone according to wobbling-in-cone model (Supplementary Information) [33]. Probe/lipid ratio used was always 1/200. Lines
are drawn as guides.
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hand, when a lipid bilayer corresponding to a 100% lo phase at room
temperature and composed of POPC:PSM:Chol (25.4:39.8:34.8mol%:
mol%:mol%) [20] was used, no signiﬁcant change in membrane ﬂuidity
was observed for either DCA or CDCA (Fig. 8B).When this last lipidmix-
ture was heated to 55 °C, there was disruption of lo and formation of ld
domains [20], and DCA induced a decrease in the ﬂuorescence anisotro-
py of DPH (Supplemental Fig. VI). This is consistent with the previous
results and conﬁrms that DCA is able to modulate ld phase ﬂuidity on
different Chol-containing compositions but is inert in lo phases. Lipo-
somes were then cooled down to 35 °C, which brought the system
back once more to the lo phase. DPH ﬂuorescence anisotropy returned
to values obtained before (Supplemental Fig. VI), indicating a loss of
DCA effect. This conﬁrmed that the phenomenaobservedwas reversible
and was an additional conﬁrmation that the effect of cytotoxic BAs was
not associated with a removal of Chol from the membrane, as this
would not be expected to be reversible.
Since cytotoxic BAs could dramatically affect the biophysical proper-
ties of Chol containingmembranes, it was possible that thesemolecules
were in fact changing the phase diagram of the POPC:PSM:Chol
mixture. In order to evaluate this, a FRET experiment was carried out
as previously described [49], using DPPE-NBD (donor) and DOPE-Rho
(acceptor) as the FRET pair. FRET efﬁciencies can be related to domain
size, since DOPE-Rho and DPPE-NBD have preference for association
with ld and lo phases, respectively [36]. FRET between the twomolecules
decreases when large domains are formed, as FRET events between
NBD-molecules in the lo phase and DOPE-Rho species in the ld phase
are not dominant. However, for domains of small size (below 75 nm
for this FRET pair), FRET events between the two lipid phases are effec-
tive and FRET efﬁciencies increase as the average domain size decreaseup to 20 nm, when FRET efﬁciencies are undistinguishable from a
homogeneous mixture [49].
Considering the phase diagram of POPC:Chol:PSM [20], 4 different
lipid compositions were chosen so that liposomes presented 0, 26, 58,
and 86% of lo phase. Liposomes were labeled either with DPPE-NBD
(donor) or with both DPPE-NBD and DOPE-Rho (donor + acceptor).
These were either incubated overnight in the absence (control) or in
the presence of 500 μM cytotoxic BA. Fluorescence intensity emission
spectra and donor ﬂuorescence lifetime were measured as a function
of % lo. FRET efﬁciencies were calculated using donor ﬂuorescence life-
time variation (Eq. (3)).
FRET efﬁciencies were always higher for the control group than for
liposomes incubated with cytotoxic BAs (Fig. 8C). In this system, a
decrease in FRET efﬁciencies could be attributed to three possible
causes: i) decrease in donor quantum yield; ii) change in domain
sizes; and iii) increase in total surface area. A decrease in donor quantum
yield would result in lower R0 values, and hence lower FRET efﬁciencies
(see Supplementary Information). In fact, a 10% decrease in the quan-
tum yield of DPPE-NBD in 100% ld was observed after DCA incubation.
However, this decrease only results in a decrease of the R0 for Rho–NBD
FRET pair from 50 Å (in the absence of BAs) to 49 Å (see Supplementary
Information). For a random distribution of donors and acceptors, these
Förster radii would lead to FRET efﬁciency decrease of only 2%, respec-
tively (see Supplementary Information). Additionally, quenching of
DPPE-NBD was also less effective for the remaining lipid compositions.
Clearly, the decrease in donor quantum yield is not responsible for the
decrease in FRET efﬁciencies after incubation with cytotoxic BAs.
Concerning changes in macroscopic domain size, these were not
observed in GUVs incubated with DCA (Supplemental Fig. VII).
Regarding the effects of cytotoxic BAs on nanoscopic domainsnot visible
Fig. 8. The inhibition of the rigidifying effect of Chol by cytotoxic BAs is only effective in the
ld phase for the POPC:PSM:Chol lipidmixture. POPC:PSM:Chol liposomes labeledwith DPH
were incubated overnight with cytotoxic BAs. Steady-state DPH ﬂuorescence anisotropy
values are shown for: (A) liposomes composed of POPC:PSM:Chol (71.6:5:23.3 mol%:
mol%:mol%), corresponding to 100% ld phase at room temperature; (B) liposomes
composed of POPC:PSM:Chol (25.4:39.8:34.8 mol%:mol%:mol%), corresponding to 100% lo
phase at room temperature. DPH was excited at 340 nm and ﬂuorescence anisotropy was
recovered at 430 nm. FRET efﬁciencies for liposomesunder ld,lo phase coexistence and load-
ed with DPPE-NBD (donor) and DOPE-Rho (acceptor) are shown (C) in the absence (gray
rhombus) or in the presence of 500 μM of DCA (black squares) or CDCA (gray circles).
The composition of liposomes under ld/lo phase coexistence followed a tie-line described
in the ternary phase diagram for POPC:Chol:PSM [20], and correspond to 71.6:5:23.3,
59.7:14:26.3, 45.1:25:29.9, 34:33.3:32.7 POPC:Chol:PSM (%mol/%mol/%mol). These compo-
sitions generated liposomes with 0, 26, 58, and 86 % of lo phase, respectively. Liposomes
were labeled with either DPPE-NBD or with both DPPE-NBD and DOPE-Rho at a ratio of
1/500 and 1/200, respectively. Fluorescence emission of DPPE-NBDwas recovered between
460 and 530 nm (λexc = 480 nm), and FRET efﬁciencies were calculated according to
Eq. (3). Lines are drawn as guides.
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FRET efﬁciencies for every lipid mixture in the tie-line, including
where no phase separation occurs at 100% ld. Additionally, FRET efﬁcien-
cies also decreased after DCA incubation in POPC-only liposomes,where
phase separation does not occur (Supplemental Fig. VIII). As such, the
decrease in FRET efﬁciencies cannot be attributed to changes in domain
sizes.
In this way, an increase in membrane surface area by BA binding
to the membrane is the most likely interpretation for the FRET data.
Upon DCA interaction with the membrane surface, it can intercalate
with the headgroups of the lipids, expanding the membrane. A 25%
increase in lipid area would justify the decrease in FRET efﬁciency for
100% ld. This increase in membrane area might help explain previous
observations of increase in membrane permeability after BA treatment
[44,50].
To summarize, cytotoxic BAs inhibit the Chol rigidifying effect on
ld membranes. This effect was not mitigated by cytoprotective BAs
and was not achieved through the removal of Chol from lipid mem-
branes. Similar results were observed for different lipid compositions
and the inhibition of cholesterol rigidifying effectwasmore pronounced
for liquid disordered membranes. This cannot be only associated with a
decrease in lo domain formation, since it was observed at Chol concen-
trations forwhich the lo phase is not present. It is possible that the lower
impact of cytotoxic BAs in lipid membranes in the lo phase is associated
with the lower membrane partition of bile acids to these membranes.
This is in agreement with the previous observation that the afﬁnity of
labeled BAs for liquid ordered membranes is signiﬁcantly smaller.4. Discussion
The determined values for the membrane partition coefﬁcients of
derivatized BAs are likely to be higher than the values for the
unlabeled molecules. In fact, derivatization results in BA charge elim-
ination and an increase in molecule hydrophobicity, and partition to
hydrophobic environments such as lipid membranes. However, given
that the ﬂuorophore is identical for both molecules, the differences
observed for membrane partition of DCA-NBD and UDCA-NBD to the
different lipidic environments must be essentially attributed to the
steroid structure of the molecule.
The BA derivatives synthesized for this study display different
afﬁnities for lipid membranes. In fact, DCA-NBD binding to lipid
membranes was signiﬁcantly more effective than UDCA-NBD binding,
while both BA derivatives exhibited signiﬁcant preference for ld
(non-raft) over lo (raft) lipid phase. In assays of apoptosis using cell
culture systems, cytotoxic BA concentration is typically at 100 μM, and
in the case of signiﬁcant partition of the BA to the plasma membrane,
a very high local density of the molecule is expected at the membrane
surface, with eventual effects on membrane structure. The difference
between membrane partition efﬁciencies observed for labeled BAs in lo
membranes was signiﬁcant (KP(lo)DCA-NBD > 2 × KP(lo)UDCA-NBD)
and, on the cholesterol-rich plasma membrane, is expected to result in
signiﬁcantly different effective concentrations of cytoprotective and
cytotoxic molecules. It is likely that this could dictate the apoptotic
potential of cytotoxic BAs, and the absence of apoptotic activity of
cytoprotective BAs.
Previous studies on the location of both cytotoxic and cytoprotective
BAs in lipid membranes have not come to a consensus. Cytoprotective
BAs have been suggested to be both intercalating with the acyl-chains
in membranes, similar to Chol [44], and adsorbed to the membrane
surface [51]. Our results clearly show that both cytotoxic and
cytoprotective BAs present very limited insertion in the membrane
interior, and are expected to have an interfacial location upon binding
to lipid membranes. In fact, results from labeled BAs suggest that both
cytotoxic and cytoprotective molecules have similar location and
dynamics in lipidmembranes, while in the absence of Chol, both classes
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by DPH photophysical data.
Additionally, high concentrations of cytoprotective BAs are unable
to inhibit the effects of DCA on the membrane structure, as seen from
the data obtained with different membrane ﬂuorescent probes, and
partition of DCA-NBD to lipid membranes is insensitive to the presence
of cytoprotective BAs. In thisway, it is very likely that the cytoprotective
role of more hydrophilic BAs is completely independent of lipid mem-
brane structure modulation, and cytoprotection is probably achieved
through a direct activation of a survival signal [10,52,53].
Interestingly, membrane probes were only sensitive to 100 μM of
BAs upon cosolubilization with all lipid components. As already
discussed, membrane partition of unlabeled BAs to lipid membranes is
likely to be less effective than the partition of the ﬂuorescent labeled
molecules studied here, but this difference in partition should be inde-
pendent of the method used for adding BAs to liposomes. Importantly,
the studies with unlabeled BAs were conducted at higher concentra-
tions (100 μM), while partition studies with labeled BAs were
performed at 2 μM. These two concentrations are likely to correspond
to different aggregation states for the molecule in solution. In this
way, our results indicate that BAs at concentrations ≥100 μM, in the
absence of binding partners, are forming premicellar stable aggregates,
with lower afﬁnity for lipid membranes. Cosolubilization of BAs with
lipid components prevents the formation of such aggregates and allows
for the effective incorporation in the lipid bilayer. It is highly feasible,
that in vivo, the presence of a large concentration of proteins and differ-
ent membrane components contribute to the solubilization of these ag-
gregates, and effective partition to membranes is in this way achieved.
Interaction of cytotoxic BAs with lipid membranes in the liquid disor-
dered phase resulted in a signiﬁcant increase in membrane surface
area, indicative of a signiﬁcant partition of BAs to the membrane. This
effect might be related to changes in membrane permeability observed
after incubation of both isolated mitochondria and model membranes
with cytotoxic BAs [44,54].
Surprisingly, cytotoxic BAs were able to disrupt to some extent the
ordering of the lipid membrane. This effect was observed in different
lipid systems andwasmore effective in the ld phase than in the lo phase,
particularly for DCA. When lo comprised most or all of the membrane
area, the ability of DCA to disorder the membrane was signiﬁcantly
reduced for both a binary and a ternary lipid mixture. On the other
hand, while CDCA was still able to decrease membrane ﬂuidity on a
POPC:Chol 60:40 mol%:mol% lipid mixture, it had no effect on a POPC:
PSM:Chol mixture in the lo phase.
Taking into account the partition behavior of ﬂuorescently labeled
BAs, it can be concluded that the absence of effects on the lo phase is
due to an absence of efﬁcient membrane binding by BAs to lo mem-
branes. In this way, it is possible that the apoptotic effect of BAs is also
achieved through changes in membrane structure or modulation of
membrane composition. Lipid rafts are essential checkpoints for
apoptotic signaling [13,55] and disturbance of this homeostasis, for
example caused by Chol deprivation, can lead to apoptosis [56,57].
Importantly, the effect of DCA on the ordering of Chol containing
membranes could not be prevented by co-incubation with cyto-
protective BAs. In fact, these molecules also induced some degree of
disordering in Chol containing membranes, albeit a much smaller one
than DCA. The co-incubation of lipid membranes with both cytotoxic
and hydrophilic BAs resulted in a cumulative effect on the membrane
order. As already discussed, it is likely that the reason why cyto-
protective BAs are not apoptotic in cell culture systems while DCA and
CDCA are strongly apoptotic at identical concentrations is associated
with differential afﬁnities for Chol-enriched lipid membranes for the
two classes of BAs.
A study on Bax activation reported that the oligomerization of Bax in
modelmembrane systemswas highly dependent onmembrane ﬂuidity
as increasing the Chol content of the membrane inhibited Bax insertion
[58]. In this way, one possible mechanism of DCA-induced apoptosiscould be an increase in ﬂuidity of themitochondrialmembrane, render-
ing it susceptible to Bax oligomerization and further damage.
To conclude, the ﬁndings presented here clearly show that
submicellar concentrations of cytotoxic BAs have the ability to induce
signiﬁcant changes in the biophysical properties of lipid membranes,
and that these changes are intimately associated with the role of Chol
in membranes. As a result of these changes, a reorganization of lipid
domain composition on the plasma membrane is expected, with likely
effects on apoptotic signaling. Alternatively, after DCA incubation, the
afﬁnity of apoptotic proteins to the mitochondrial membrane could be
signiﬁcantly altered, potentially triggering apoptosis.
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